Showing results (221-230 of 554) with videos related to

Sort By:
Pageof 56
Journal of Virology|April 13, 2012
Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infectionChristina F Thobakgale, Lena Fadda, Kimberly Lane, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Ebiomedicine|October 10, 2020
An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South AfricaElouise E Kroon, Craig J Kinnear, Marianna Orlova, et al.
Nature Communications|August 24, 2023
Antibody-mediated NK cell activation as a correlate of immunity against influenza infectionCarolyn M Boudreau, John S Burke, Ashraf S Yousif, et al.
Mbio|April 13, 2026
Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammationSamantha R Mackin, Chieh-Yu Liang, Courtney E Karl, et al.
Frontiers in Immunology|November 16, 2020
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γAndy C Tran, Gil R Diogo, Matthew J Paul, et al.
Vaccines|October 27, 2022
Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated MothersMadeleine D Burns, Cordelia Muir, Caroline Atyeo, et al.
Nature Reviews. Immunology|June 14, 2018
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D Simmons, Catherine M Stein, Chetan Seshadri, et al.
Nature Microbiology|April 3, 2023
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
NPJ Vaccines|January 31, 2026
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infectionShlomi Ilan, Yannic Bartsch, Wonyeong Jung, et al.
Pageof 56